pergolide has been researched along with d-alpha tocopherol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berg, MJ; Collier, DS; Fincham, RW | 1 |
| Canonico, PL; Carsana, T; Ferrari Toninelli, G; Francisconi, S; Memo, M; Uberti, D | 1 |
2 review(s) available for pergolide and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Parkinsonism treatment: Part III--Update.
Topics: Antioxidants; Dopamine Agents; Female; Fetal Tissue Transplantation; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline; Vitamin E | 1992 |
1 other study(ies) available for pergolide and d-alpha tocopherol
| Article | Year |
|---|---|
A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation.
Topics: Active Transport, Cell Nucleus; Analysis of Variance; Humans; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Peptides; Pergolide; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vitamin E | 2004 |